AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimixia-VM1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Wings Biotech Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimixia-VM1 Tablet ER

Diabetica-MX1 Extended Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetica-MX1 ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor; lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect; learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to treat it promptly. Maintain regular mealtimes and always carry a readily available fast-acting glucose source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should consult their physician before initiating treatment. Consult your doctor before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to monitor blood cell counts and liver function.

Uses of Glimixia-VM1 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimixia-VM1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glimixia-VM1 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet on an empty stomach.

Common Side effects of Glimixia-VM1 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimixia-VM1 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimixia-VM1 Extended-Release tablets should be administered on an empty stomach.

How Glimixia-VM1 Tablet ER works:

Extended-release Glimixia-VM1 tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glimixia-VM1 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimixia-VM1 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimixia-VM1 Tablet likely poses a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, possibly causing harm to the nursing child.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimixia-VM1 Tablet ER is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, this medication is contraindicated in patients with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Glimixia-VM1 Tablet ER cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, Glimixia-VM1 Tablet ER therapy typically begins with a reduced dose; however, it's contraindicated in patients exhibiting severe liver disease.

What if you forget to take Glimixia-VM1 Tablet ER :

Should you forget a dose of Glimixia-VM1 Extended-Release Tablets, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimixia-VM1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimixia-VM1 Tablet ER

Glimixia-VM1 Tablet ER combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination, used with diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. It's not suitable for type 1 DM.
Glimixia-VM1 Tablet ER may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, skin rash, and respiratory infection.
Glimixia-VM1 Tablet ER is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimixia-VM1 ER tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glimixia-VM1 Tablet ER can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimixia-VM1 Tablet ER
108
MRP 125
13% off